The association between angiotensinconverting enzyme 2 polymorphisms and essential hypertension risk: A metaanalysis involving 14,122 patients

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 16, Issue 4, 2015, Pages 1240-1244

  Yang, Mei ^a   Zhao, Jing ^b   Xing, Lin ^a   Shi, Li ^a  

^a Third People's Hospital of Jinan   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

ACE2; Essential hypertension; Genetics; Meta analysis; Polymorphism

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE;

ENZYMOLOGY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN; HYPERTENSION; META ANALYSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ANGIOTENSIN CONVERTING ENZYME 2 GENE; ARTICLE; ESSENTIAL HYPERTENSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; SEX DIFFERENCE;

GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84952940652     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320314549221     Document Type: Article

References (26)

1. Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275: 33238-33243.
2. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin- converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: E1-E9.
3. Burrell LM, Johnston CI, Tikellis C, et al. ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol Metab 2004; 15: 166-169.
4. Yagil Y and Yagil C. Hypothesis: ACE2 modulates blood pressure in the mammalian organism. Hypertension 2003; 41: 871-873.
5. Benjafield AV, Wang WY and Morris BJ. No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am J Hypertens 2004; 17: 624-628.
6. Liu TB, Shang HP, Zhang KX, et al. Association of angiotensin I converting enzyme 2 gene polymorphism with essential hypertension in Chinese [article in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22: 569-571.
7. Huang W, Yang W, Wang Y, et al. Association study of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms and essential hypertension in northern Han Chinese. J Hum Hypertens 2006; 20: 968-971.
8. Yi L, Gu YH, Wang XL, et al. Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. J Int Med Res 2006; 34: 272-283.
9. Fan X, Wang Y, Sun K, et al. Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of captopril in women. Clin Pharmacol Ther 2007; 82: 1-10.
10. Niu W, Qi Y, Hou S, et al. Correlation of angiotensinconverting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese. Transl Res 2007; 150: 374-380.
11. Zhang CJ, Shan ZX, Chen FR, et al. Association of angiotensin converting enzyme 2 gene polymorphisms with essential hypertension. South China Journal of Cardiovascular Diseases 2007; 13: 88-92.
12. Fan XH, Wang YB, Wang H, et al. Polymorphisms of angiotensin-converting enzyme (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in hypertensive patients. Acta Pharmacol Sin 2009; 30: 1237-1244.
13. Si DN and Li L. Association study of angiotensin-converting enzyme 2 gene polymorphism with essential hypertension and essential hypertension with type 2 diabetes mellitus. Chin J Pract Nerv Dis 2009; 12: 28-30.
14. Jiang XB, Zhang DF, Jiang WJ, et al. Association of angiotensin- converting enzyme 2 (ACE2) gene G8790A polymorphism with essential hypertension in Han Chinese. Chin Gen Pract 2010; 13: 3274-3277.
15. Qu H and Gao DL. To explore the relationship between angiotensin-converting enzyme 2 gene G8790A polymorphism with essential hypertension and metabolic syndrome. Chin Rem Clinics 2010; 10: 895-898.
16. Zhang Y, Wu K, Jin SJ, et al. Association of angiotensin converting enzyme 2 gene polymorphism with essential hypertension in Chinese minority of Hainan province. Chin J Gerontol 2010; 30: 1029-1030.
17. Hu SL, Chen WZ, Li M, et al. Association between polymorphism of angiotensin converting enzyme 2 gene A9570G and hypertension with left ventricular hypertrophy. Chin J Cardiovasc Med 2012; 17: 201-204.
18. Li GQ and Fan JM. Relationship between the angiotensin converting enzyme 2 gene polymorphism and antihypertensive effect of valsartan. J Chin Physician 2012; 14: 868-873.
19. Patnaik M, Pati P, Swain SN, et al. Association of angiotensin- converting enzyme and angiotensin-converting enzyme-2 gene polymorphisms with essential hypertension in the population of Odisha, India. Ann Hum Biol 2014; 41: 143-150.
20. Lu N, Yang Y, Wang Y, et al. ACE2 gene polymorphism and essential hypertension: An updated meta-analysis involving 11, 051 subjects. Mol Biol Rep 2012; 39: 6581-6589.
21. Li YY. Lack of association of ACE2 G8790A gene mutation with essential hypertension in the Chinese population: A meta-analysis involving 5260 subjects. Front Physiol 2012; 3: 364.
22. Zhou JB and Yang JK. Meta-analysis of association of ACE2 G8790A polymorphism with Chinese Han essential hypertension. J Renin Angiotensin Aldosterone Syst 2009; 10: 31-34.
23. Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
24. Burrell LM, Harrap SB, Velkoska E, et al. The ACE2 gene: Its potential as a functional candidate for cardiovascular disease. Clin Sci (Lond) 2013; 124: 65-76.
25. Kramkowski K, Mogielnicki A and Buczko W. The physiological significance of the alternative pathways of angiotensin II production. J Physiol Pharmacol 2006; 57: 529-539.
26. Blackwood EM and Kadonaga JT. Going the distance: A current view of enhancer action. Science 1998; 281: 60-63.